IL18 and Hyperglycemia: In all participants, hyperglycemia led to significant reductions of 62/70 inflammatory markers across all subcategories (Table 2) including TNF-α (Fig. 2a), IL-8 (Fig. 2c), IL-18 (Fig. 2d) and VEGF-A (Fig. 2e).